Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits. (Q38344507)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

review article

1 reference

title

Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Rex M Philpot

series ordinal

1

1 reference

2 September 2017

5 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

published in

Neurochemical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

2018-2031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25652578%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11064-015-1528-y

29 February 2020

exact match

0 references

cites work

Low neuropsychologic performance among adult cancer survivors treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Candidate mechanisms for chemotherapy-induced cognitive changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive impairment associated with chemotherapy for cancer: report of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chemotherapy and cognitive defects in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neuropsychological sequelae of non-central nervous system cancer and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neurocognitive changes in cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Mild cognitive impairment: conceptual issues and structural and functional brain correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Regional brain activation during verbal declarative memory in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Prefrontal cortex and executive function impairments in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Prechemotherapy alterations in brain function in women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: A functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chemotherapy and cognitive impairment: treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The effect of modafinil on cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic modulation of neuronal networks: from receptors to cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine self-medication of cognitive-attentional processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Meta-analysis of the acute effects of nicotine and smoking on human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine and nicotinic receptor involvement in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The effects of chemotherapy on cognitive function in a mouse model: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive effects of endocrine-disrupting chemicals in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Endocrine regulation of cognition and neuroplasticity: our pursuit to unveil the complex interaction between hormones, the brain, and behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effects of oestrogen on cognition: what have we learned from basic research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Hippocampal theta activity and the attention component of discrimination learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Analysis of temporal relations among units and slow waves in rabbit hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Brain oscillations and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cerebellar theta oscillations are synchronized during hippocampal theta-contingent trace conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Synchronous neural activity and memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Hippocampo-cerebellar theta band phase synchrony in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chemotherapy disrupts learning, neurogenesis and theta activity in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine in an animal model of attention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Olanzapine interactions with nicotine and mecamylamine in rats: effects on memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced func

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Comparative effects of the alpha7 nicotinic partial agonist, S 24795, and the cholinesterase inhibitor, donepezil, against aging-related deficits in declarative and working memory in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neuronal responses related to long-term recognition memory processes in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Alpha7 nicotinic acetylcholine receptor activation ameliorates scopolamine-induced behavioural changes in a modified continuous Y-maze task in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The performance of human infants on a measure of frontal cortex function, the delayed response task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Contrasting effects of excitotoxic lesions of the prefrontal cortex on the behavioural response to D-amphetamine and presynaptic and postsynaptic measures of striatal dopamine function in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Differential regulation of fronto-executive function by the monoamines and acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Hippocampal-anterior thalamic pathways for memory: uncovering a network of direct and indirect actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Qualitatively different modes of perirhinal-hippocampal engagement when rats explore novel vs. familiar objects as revealed by c-Fos imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Magnitude of the object recognition deficit associated with perirhinal cortex damage in rats: Effects of varying the lesion extent and the duration of the sample period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Entorhinal cortex lesions disrupt the relational organization of memory in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic receptor activation in perirhinal cortex and hippocampus enhances object memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine improves memory in an object recognition task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cholinergic drugs affect novel object recognition in rats: relation with hippocampal EEG?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Hippocampus and context in classical conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Neurotoxic lesions of the dorsal hippocampus and Pavlovian fear conditioning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Electrolytic lesions of the fimbria/fornix, dorsal hippocampus, or entorhinal cortex produce anterograde deficits in contextual fear conditioning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Disrupting neural activity related to awake-state sharp wave-ripple complexes prevents hippocampal learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

An animal model to detect the neuropsychological toxicity of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cancer chemotherapy impairs contextual but not cue-specific fear memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Compound K is able to ameliorate the impaired cognitive function and hippocampal neurogenesis following chemotherapy treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine improves learning and memory in rats: morphological evidence for acetylcholine involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine improves cognitive disturbance in senescence-accelerated mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine enhancement of contextual fear conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine enhances contextual fear memory reconsolidation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Mecamylamine reversal by nicotine and by a partial alpha7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

The enhancement of contextual fear conditioning by ABT-418.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Antiamnestic effect of alpha7-nicotinic receptor agonist RJR-2403 in middle-aged ovariectomized rats with Alzheimer type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Protective effect of GTS-21, a novel nicotinic receptor agonist, on delayed neuronal death induced by ischemia in gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Place navigation impaired in rats with hippocampal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Low-dose nicotine facilitates spatial memory in ApoE-knockout mice in the radial arm maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Post-learning REM sleep deprivation impairs long-term memory: reversal by acute nicotine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Intensification of long-term memory deficit by chronic stress and prevention by nicotine in a rat model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine attenuates spatial learning deficits induced in the rat by perinatal lead exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine attenuates spatial learning deficits induced by sodium metavanadate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine improves AF64A-induced spatial memory deficits in Morris water maze in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine inhibits cisplatin-induced apoptosis in NCI-H446 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine induces resistance to chemotherapy in nasal epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Improvement of attentional function with antagonism of nicotinic receptors in female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Complex relationships of nicotinic receptor actions and cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Persistence of nicotinic agonist RJR 2403-induced working memory improvement in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1528-Y

Short introduction and history

21 January 2018

1 reference

12 December 2020

Nicotine decreases the cytotoxicity of doxorubicin towards MCF-7 and KB-3.1 human cancer cells in culture

1 reference

12 December 2020

Organic factors and psychological adjustment in advanced cancer patients

1 reference

12 December 2020

Nicotine enhances sustained attention in the rat under specific task conditions

1 reference

12 December 2020

Cognitive impact of cytotoxic agents in mice

1 reference

12 December 2020

Is"chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer

1 reference

12 December 2020

Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction.

1 reference

12 December 2020

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.

1 reference

12 December 2020

Nicotinic-antipsychotic drug interactions and cognitive function.

1 reference

12 December 2020

Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients

1 reference

12 December 2020

Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study

1 reference

12 December 2020

Impaired recognition memory in rats after damage to the hippocampus.

1 reference

12 December 2020

Hippocampus and contextual fear conditioning: recent controversies and advances

1 reference

12 December 2020

Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime.

1 reference

12 December 2020

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

12 December 2020

Chemotherapy may have small to moderate negative effects on cognitive functioning

1 reference

12 December 2020

Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging

1 reference

12 December 2020

Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives

1 reference

12 December 2020

Effects of nicotine on spatial learning in C57BL mice.

1 reference

12 December 2020

Medial frontal cortex mediates perceptual attentional set shifting in the rat.

1 reference

12 December 2020

Serial cognitive testing in cancer patients receiving chemotherapy

1 reference

12 December 2020

White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.

1 reference

12 December 2020

DMXB (GTS-21) ameliorates the cognitive deficits in beta amyloid(25-35(-) ) injected mice through preventing the dysfunction of alpha7 nicotinic receptor

1 reference

12 December 2020

AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.

1 reference

12 December 2020

Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat

1 reference

12 December 2020

Biological significance in forward and backward blocking: resolution of a discrepancy between animal conditioning and human causal judgment.

1 reference

12 December 2020

Breast cancer chemotherapy-related cognitive dysfunction.

1 reference

12 December 2020

Treatment modality affects long-term quality of life in gynaecological cancer.

1 reference

12 December 2020

Acute nicotine treatment prevents REM sleep deprivation-induced learning and memory impairment in rat.

1 reference

12 December 2020

RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization

1 reference

12 December 2020